2016-03-05T00:00:00.000-05:00
development,0.245416
ovarian cancer,-0.409365
email newsletter,0.583352
price target,0.560499
oral formulation,-0.291204
cell immune response,-0.384241
email address,0.510822
related companies,0.583352
InvestorPlace Broker Center,0.555736
high fees,-0.735674
research report,0.264333
outperform rating,0.523397
Zacks Investment Research,0.40995
personal trading style,0.598412
latest news,0.510822
target price,0.475783
Roth Capital,0.264333
AnalystRatingsNetwork.com reports,-0.247432
buy rating,0.494334
research note,0.428168
HC Wainwright,0.428168
autologous dendritic cell,-0.409365
BioMed Ltd Daily,0.405934
research offerings,0.40995
shares,0.428168
concise daily summary,0.510822
licensed medical biotechnology,0.245416
cancer immunotherapy research,-0.541668
coverage,0.264333
prima biomed,0.090593
stock broker,0.245696
Human Papilloma Virus,-0.291204
